Study by IDOR Analyzed 11 Years of Data on Hospitalizations and Mortality from Chronic Pancreatitis in Brazil
A new study led by the D’Or Institute for Research and Education (IDOR) and the Federal University of Rio de Janeiro (UFRJ), published in the journal Digestive Diseases and Sciences, analyzed trends and the geographic distribution of chronic pancreatitis across Brazil over the past 11 years. This disease, which is associated with an increased risk of pancreatic cancer, has shown a sharp decline in hospitalizations over the years, yet mortality rates have remained steady, especially among the elderly, smokers, and residents of the Southern and Southeastern regions.
Chronic Pancreatitis in Brazil
Chronic pancreatitis is an inflammatory condition of the pancreas that causes progressive damage, leading to serious complications such as pancreatic insufficiency, diabetes, and an increased risk of developing pancreatic cancer. For those affected, the debilitating symptoms significantly impact their quality of life, while the healthcare system faces the high cost of hospitalizations and long-term treatments. The situation is even more concerning in developing countries like Brazil, where access to specialized healthcare is limited, and regional inequalities can worsen the problem.
Given the lack of comprehensive data on chronic pancreatitis in the country, researchers from IDOR and UFRJ conducted an extensive study to better understand the disease’s epidemiology in Brazil over the 11 years leading up to the COVID-19 pandemic.